Search Results - "Seminars in thrombosis and hemostasis"
-
1
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies
Published in Seminars in thrombosis and hemostasis (01-10-2020)“…Coronavirus disease 2019 (COVID-19) may have a wide spectrum of clinical presentations, leading in some cases to a critical condition with poor long-term…”
Get more information
Journal Article -
2
Next-Generation Sequencing and Emerging Technologies
Published in Seminars in thrombosis and hemostasis (01-10-2019)“…Genetic sequencing technologies are evolving at a rapid pace with major implications for research and clinical practice. In this review, the authors provide an…”
Get more information
Journal Article -
3
Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation
Published in Seminars in thrombosis and hemostasis (01-02-2018)“…Extracorporeal membrane oxygenation (ECMO) has been used for >40 years to support lung and heart failure; however, bleeding and thrombosis remain serious…”
Get more information
Journal Article -
4
Platelet Physiology
Published in Seminars in thrombosis and hemostasis (01-04-2016)“…Platelets are the smallest blood cells, numbering 150 to 350 × 10(9)/L in healthy individuals. The ability of activated platelets to adhere to an injured…”
Get more information
Journal Article -
5
-
6
-
7
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)
Published in Seminars in thrombosis and hemostasis (01-04-2023)“…Plasminogen activator inhibitor 1 (PAI-1), a SERPIN inhibitor, is primarily known for its regulation of fibrinolysis. However, it is now known that this…”
Get more information
Journal Article -
8
The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis
Published in Seminars in thrombosis and hemostasis (01-03-2017)“…Extracellular matrix (ECM) deposition during wound healing is a physiological response to an insult. Wound healing becomes deregulated in the setting of…”
Get more information
Journal Article -
9
Environmental and Genetic Risk Factors Associated with Venous Thromboembolism
Published in Seminars in thrombosis and hemostasis (01-11-2016)“…Venous thromboembolism (VTE) includes deep vein thrombosis and pulmonary embolism, and a combination of environmental and genetic risk factors contributes to…”
Get more information
Journal Article -
10
Congenital fibrinogen disorders: an update
Published in Seminars in thrombosis and hemostasis (01-09-2013)“…Hereditary fibrinogen abnormalities comprise two classes of plasma fibrinogen defects: Type I, afibrinogenemia or hypofibrinogenemia, which has absent or low…”
Get more information
Journal Article -
11
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection
Published in Seminars in thrombosis and hemostasis (01-10-2020)Get more information
Journal Article -
12
Thrombin: A Pivotal Player in Hemostasis and Beyond
Published in Seminars in thrombosis and hemostasis (01-10-2021)“…The serine protease thrombin, a naturally derived enzyme, plays a key role in hemostasis by converting fibrinogen to fibrin and activating coagulation factor…”
Get more information
Journal Article -
13
Factor XII Contact Activation
Published in Seminars in thrombosis and hemostasis (01-11-2017)“…Contact activation is the surface-induced conversion of factor XII (FXII) zymogen to the serine protease FXIIa. Blood-circulating FXII binds to negatively…”
Get more information
Journal Article -
14
Bleeding and Bleeding Risk in COVID-19
Published in Seminars in thrombosis and hemostasis (01-10-2020)Get more information
Journal Article -
15
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?
Published in Seminars in thrombosis and hemostasis (01-02-2022)“…Antiphospholipid antibodies (aPL) comprise a panel of autoantibodies that reflect a potential prothrombotic risk in several autoimmune conditions, most notably…”
Get more information
Journal Article -
16
NETosis: a new factor in tumor progression and cancer-associated thrombosis
Published in Seminars in thrombosis and hemostasis (01-04-2014)“…Neutrophils have long been known as innate immune cells that phagocytose and kill pathogens and mount inflammatory responses protecting the host from…”
Get more information
Journal Article -
17
Platelet Activation and Thrombosis in COVID-19
Published in Seminars in thrombosis and hemostasis (01-02-2023)“…Although thrombosis frequently occurs in infectious diseases, the coagulopathy associated with COVID-19 has unique characteristics. Compared with bacterial…”
Get more information
Journal Article -
18
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism
Published in Seminars in thrombosis and hemostasis (01-10-2020)Get more information
Journal Article -
19
Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis
Published in Seminars in thrombosis and hemostasis (01-03-2024)“…The prevailing hypotheses for the persistent symptoms of Long COVID have been narrowed down to immune dysregulation and autoantibodies, widespread organ…”
Get more information
Journal Article -
20
The Role of Fibrin(ogen) in Wound Healing and Infection Control
Published in Seminars in thrombosis and hemostasis (01-03-2022)“…Fibrinogen, one of the most abundant plasma proteins playing a key role in hemostasis, is an important modulator of wound healing and host defense against…”
Get more information
Journal Article